See also this year's filing and all EDGAR filings for this company.
PDF Report 0001396814_2020_Pacira_Biosciences_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 421026000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 429647000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001396814, Pacira Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 408,557,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 203,934,000 |
| 2 | PropertyPlantAndEquipmentNet | 104,681,000 |
| 3 | remainder_Assets | 113,893,000 |
| 4 | LiabilitiesCurrent | 107,673,000 |
| 5 | LiabilitiesNoncurrent | 42,440,000 |
| 6 | remainder_Liabilities | 326,008,000 |
| 7 | CostOfGoodsAndServicesSold | 128,192,340 |
| 8 | SellingGeneralAndAdministrativeExpense | 207,466,999 |
| 9 | ResearchAndDevelopmentExpense | 87,096,149 |
| 10 | remainder_Expenses | 179,088,044 |
| 11 | remainder_Revenues | 464,254,997 |
| 12 | remainder_NetIncome | -25,776,134 |
| 13 | remainder_ComprehensiveNetIncome | 2,741,997 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 831,065,000 |
| 1 | Liabilities | 476,121,000 |
| 2 | Expenses | 601,843,532 |
| 3 | Revenues | 464,254,997 |
| 4 | StockholdersEquity | 354,944,000 |
| 5 | NetIncome | -163,364,669 |
| 6 | ComprehensiveNetIncome | -161,993,670 |
| 7 | BaseVar | 1,200,901,330 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.936 |
| 9 | EconomicCapitalRatio | 2.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
